RxDoctor Payments Data

Traci Hartsfield

Medical · Marietta, GANPI 1407986540

Payments from drug & device makers

$2,709in general payments, 2019–2025

Across 137 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$658
  • Boehringer Ingelheim$326
  • Merck$254
  • Amgen$234
  • Esperion Therapeutics, Inc.$226
  • Johnson & Johnson$200
  • plus $811 from 17 others

What the payments were for

  • Food & beverage$2,709100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,709 in reported general payments places this provider in the 70th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$50,704
Medicare patients
426
Services billed
685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban93$107,654
EntrestoSacubitril/Valsartan76$79,962
JardianceEmpagliflozin87$73,436
XareltoRivaroxaban36$38,466
FarxigaDapagliflozin Propanediol14$13,305
Repatha SureclickEvolocumab13$11,332
Ranolazine ErRanolazine25$4,389
Dabigatran EtexilateDabigatran Etexilate Mesylate12$3,974
Metoprolol Succinate186$2,707
Clonidine11$2,450
Rosuvastatin Calcium135$2,026
Potassium Chloride108$1,585
Hydralazine Hcl190$1,491
Ezetimibe34$1,091
Carvedilol159$1,085

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$161$107,65493 claims
NovartisEntresto$658$79,96276 claims
Boehringer IngelheimJardiance$326$73,43687 claims
Johnson & JohnsonXarelto$200$38,46636 claims
AstraZenecaFarxiga$20$13,30514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 950 medical providers in Georgia.

Other medical in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →